Switch to
More onapp

Syncom Formulations (India) Ltd

SYNCOMF
Health CarePharmaceuticals
SmallcapWith a market cap of ₹741 cr, stock is ranked 1,167
High RiskStock is 3.13x as volatile as Nifty
7.800.00 (+0.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹741 cr, stock is ranked 1,167
High RiskStock is 3.13x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
37.51
PB RatioPB Ratio
3.34
Dividend YieldDiv. Yield
0.35%
Sector PESector PE
34.26
Sector PBSector PB
4.19
Sector Div YldSctr Div Yld
0.92%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Syncom Formulations (India) Limited is a pharmaceutical company that manufactures and markets over 300 pharmaceutical formulations products. It also exports various commodities such as agro and confectionary products and industrial products.

Financial TrendFinancial statements 

2019202020212022191.85210.73251.98231.6811.0914.2629.1819.77
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Updates 
Announced OnJan 19, 2023

Syncom Formulations (India) Limited has informed the Exchange regarding 'Syncom Formulations (India) Limited has informed the Exchange about the SDD Certificate for the Quarter ended 31st December,2022. '. | Download

Syncom Formulations (India) Limited has informed the Exchange regarding 'Syncom Formulations (India) Limited has informed the Exchange about the SDD Certificate for the Quarter ended 31st December,2022. '. | Download

Certificate under SEBI (Depositories and Participants) Regulations, 2018 
Announced OnJan 9, 2023

Syncom Formulations (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Download

Syncom Formulations (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Download

Cash Dividend 
Ex. DateSep 9, 2022

Final • Div/Share: ₹ 0.03

See all events